LAMEA Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030

The Latin America, Middle East and Africa Arthritic Therapeutic Market would witness market growth of 7.4% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Arthritic Therapeutic Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,461.1 Million by 2030. The Argentina market is showcasing a CAGR of 7.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7% during (2023 - 2030).

Arthritic therapeutics encompass a range of interventions aimed at preserving joint integrity and promoting tissue repair in individuals with degenerative forms of arthritis, such as osteoarthritis. Joint-preserving procedures, including arthroscopy, osteotomy, and cartilage restoration techniques, help address mechanical abnormalities, redistribute load forces, and repair damaged cartilage, thereby delaying joint replacement surgery and prolonging the lifespan of affected joints.

Pain management is a central component of arthritis care, and the therapeutics encompass various modalities to reduce pain and improve functional outcomes. Physical therapy, occupational therapy, and exercise programs help strengthen muscles, improve joint flexibility, and enhance mobility, mitigating pain and improving overall physical function. Assistive devices, such as orthoses, braces, and splints, provide support and stability to arthritic joints, reducing pain and preventing further injury.

Knee osteoarthritis is becoming increasingly prevalent in the LAMEA region due to factors such as population aging, urbanization, sedentary lifestyles, and obesity. With the rising prevalence of knee osteoarthritis, there is a corresponding increase in healthcare spending in the LAMEA region as governments, healthcare systems, and payers allocate resources to address the healthcare needs of individuals with musculoskeletal conditions. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.

Free Valuable Insights: The Worldwide Arthritic Therapeutic Market is Projected to reach USD 112.6 Billion by 2030, at a CAGR of 5.1%

Based on Application, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others. Based on Product Type, the market is segmented into Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• AbbVie, Inc.
• Pfizer, Inc.
• Amgen, Inc.
• Novartis AG
• F.Hoffmann-La Roche Ltd.
• Viatris, Inc.
• Bausch Health Companies, Inc.
• Sanofi S.A.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company

LAMEA Arthritic Therapeutic Market Report Segmentation

By Application

• Rheumatoid Arthritis
• Psoriatic Arthritis
• Osteoarthritis
• Ankylosing Spondylitis
• Others

By Product Type

• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Disease Modified Anti-rheumatoid Drugs (DMARDs)
• Biologics
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Arthritic Therapeutic Market, by Application
1.4.2 LAMEA Arthritic Therapeutic Market, by Product Type
1.4.3 LAMEA Arthritic Therapeutic Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5. LAMEA Arthritic Therapeutic Market, by Application
5.1 LAMEA Rheumatoid Arthritis Market, by Country
5.2 LAMEA Psoriatic Arthritis Market, by Country
5.3 LAMEA Osteoarthritis Market, by Country
5.4 LAMEA Ankylosing Spondylitis Market, by Country
5.5 LAMEA Others Market, by Country

Chapter 6. LAMEA Arthritic Therapeutic Market, by Product Type
6.1 LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
6.2 LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
6.3 LAMEA Biologics Market, by Country
6.4 LAMEA Others Market, by Country

Chapter 7. LAMEA Arthritic Therapeutic Market, by Country
7.1 Brazil Arthritic Therapeutic Market
7.1.1 Brazil Arthritic Therapeutic Market, by Application
7.1.2 Brazil Arthritic Therapeutic Market, by Product Type
7.2 Argentina Arthritic Therapeutic Market
7.2.1 Argentina Arthritic Therapeutic Market, by Application
7.2.2 Argentina Arthritic Therapeutic Market, by Product Type
7.3 UAE Arthritic Therapeutic Market
7.3.1 UAE Arthritic Therapeutic Market, by Application
7.3.2 UAE Arthritic Therapeutic Market, by Product Type
7.4 Saudi Arabia Arthritic Therapeutic Market
7.4.1 Saudi Arabia Arthritic Therapeutic Market, by Application
7.4.2 Saudi Arabia Arthritic Therapeutic Market, by Product Type
7.5 South Africa Arthritic Therapeutic Market
7.5.1 South Africa Arthritic Therapeutic Market, by Application
7.5.2 South Africa Arthritic Therapeutic Market, by Product Type
7.6 Nigeria Arthritic Therapeutic Market
7.6.1 Nigeria Arthritic Therapeutic Market, by Application
7.6.2 Nigeria Arthritic Therapeutic Market, by Product Type
7.7 Rest of LAMEA Arthritic Therapeutic Market
7.7.1 Rest of LAMEA Arthritic Therapeutic Market, by Application
7.7.2 Rest of LAMEA Arthritic Therapeutic Market, by Product Type

Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Amgen, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Novartis AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Viatris, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Trials and Approvals:
8.6.6 SWOT Analysis
8.7 Bausch Health Companies, Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Bristol-Myers Squibb Company
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

TABLE 1 LAMEA Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4 LAMEA Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5 LAMEA Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16 LAMEA Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17 LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 27 Brazil Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28 Brazil Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29 Brazil Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30 Brazil Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31 Brazil Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 32 Brazil Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 33 Argentina Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 34 Argentina Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 35 Argentina Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 36 Argentina Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 37 Argentina Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 38 Argentina Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 39 UAE Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 40 UAE Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 41 UAE Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 42 UAE Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 43 UAE Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 44 UAE Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 45 Saudi Arabia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 46 Saudi Arabia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 47 Saudi Arabia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 48 Saudi Arabia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 49 Saudi Arabia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 50 Saudi Arabia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 51 South Africa Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 52 South Africa Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 53 South Africa Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 54 South Africa Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 55 South Africa Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 56 South Africa Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 57 Nigeria Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 58 Nigeria Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 59 Nigeria Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 60 Nigeria Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 61 Nigeria Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 62 Nigeria Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 63 Rest of LAMEA Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 64 Rest of LAMEA Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 65 Rest of LAMEA Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 66 Rest of LAMEA Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 67 Rest of LAMEA Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 68 Rest of LAMEA Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 69 Key information – AbbVie, Inc.
TABLE 70 Key Information – Pfizer, Inc.
TABLE 71 Key Information – Amgen, Inc.
TABLE 72 Key Information – Novartis AG
TABLE 73 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 74 Key Information – Viatris, Inc.
TABLE 75 key information – Bausch Health Companies, Inc.
TABLE 76 Key Information – Sanofi S.A.
TABLE 77 Key Information - Merck & Co., Inc.
TABLE 78 Key Information – Bristol-Myers Squibb Company

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Arthritic Therapeutic Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Arthritic Therapeutic Market
FIG 4 Porter’s Five Forces Analysis - Arthritic Therapeutic Market
FIG 5 LAMEA Arthritic Therapeutic Market share, by Application, 2022
FIG 6 LAMEA Arthritic Therapeutic Market share, by Application, 2030
FIG 7 LAMEA Arthritic Therapeutic Market, by Application, 2019 - 2030, USD Million
FIG 8 LAMEA Arthritic Therapeutic Market share, by Product Type, 2022
FIG 9 LAMEA Arthritic Therapeutic Market share, by Product Type, 2030
FIG 10 LAMEA Arthritic Therapeutic Market, by Product Type, 2019 - 2030, USD Million
FIG 11 LAMEA Arthritic Therapeutic Market share, by Country, 2022
FIG 12 LAMEA Arthritic Therapeutic Market share, by Country, 2030
FIG 13 LAMEA Arthritic Therapeutic Market, by Country, 2019 - 2030, USD Million
FIG 14 Swot Analysis: AbbVie, Inc.
FIG 15 SWOT Analysis: Pfizer, Inc.
FIG 16 Swot Analysis: Amgen, Inc.
FIG 17 SWOT Analysis: Novartis AG
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: Viatris, Inc.
FIG 20 SWOT Analysis: Bausch Health Companies, Inc.
FIG 21 Swot Analysis: Sanofi S.A.
FIG 22 SWOT Analysis: Merck & Co., Inc.
FIG 23 SWOT Analysis: Bristol-Myers Squibb Company